|  | 
  
  
 Vaccine Detail
                          
                            | SARS-CoV S Baculovirus Vaccine |  
                            | Vaccine Information |  
                            | 
							  Vaccine Name: SARS-CoV S Baculovirus VaccineTarget Pathogen: SARS-CoVTarget Disease: Severe Acute Respiratory Syndrome (SARS)Vaccine Ontology ID: VO_0005151Type: Recombinant vector vaccineStatus: ResearchHost Species for Licensed Use: NoneHost Species as Laboratory Animal Model: Mouse, RatAntigen: S protein of SARS-CoV (Zhou et al., 2006)Immunization Route: intranasal immunizationDescription: recombinant SARS-CoV spike (S) glycoprotein viral vaccine produced in insect cells that is expressed by baculovirus (Zhou et al., 2006) |  
                            | Host Response |  
                            |  |  
                  | References |  
                            | Zhou et al., 2006: Zhou Z, Post P, Chubet R, Holtz K, McPherson C, Petric M, Cox M. A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice. Vaccine. 2006; 24(17); 3624-3631. [PubMed: 16497416]. |  |